Microbe/phage investigation for generalized health therapy
Active Other Transaction Agreement Awarded Last action
- Contract number
- 140D042590030
- Awardee
-
University Of Illinois UEI Y8CWNJRCNN91
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $28,073,294
Award facts
- Contract value 86% obligated
-
- $28,073,294.00 Current, with exercised options
- $32,751,928.00 Potential, with all options
- Completion date 22% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Urbana, IL 61801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $28,073,294 |
About this award
The National Institutes of Health has awarded the University of Illinois a $32.8 million Other Transaction Agreement for the Microbe/Phage Investigation for Generalized Health Therapy (MIGHTY) program, with performance at the university's Urbana, Illinois location and completion targeted for September 2030. This contract, awarded September 22, 2025, does not carry a set-aside designation and represents a collaborative research initiative focused on investigating microbes and bacteriophages for therapeutic applications. The University of Illinois is serving as the prime contractor, leveraging its extensive federal research portfolio and expertise in biomedical research, which aligns with NIH's mission in advancing health-related scientific discovery.
The contract involves two significant subcontractors: Ginkgo Bioworks, Inc., a Boston-based biotechnology company specializing in cellular engineering and genomic surveillance that has established expertise through prior work with the Centers for Disease Control and Prevention and Defense Advanced Research Projects Agency, and Baylor University, a private research institution with substantial experience in medical research and advanced scientific initiatives. This multi-institutional structure enables the integration of complementary capabilities in microbial biology, phage research, and translational health applications, positioning the collaborative effort to advance therapeutic innovations in generalized health therapy through rigorous scientific investigation and development.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Regents Of The University Of Minnesota | $643,571 | |
| Oregon State University | $151,273 | |
| Ginkgo Bioworks, Inc. | $902,193 | |
| Baylor University | $1,217,168 |
Quick answers
Who was awarded contract 140D042590030?
140D042590030 was awarded to University Of Illinois by Interior Business Center (Office of Policy Management and Budget) on September 22, 2025.
How much is contract 140D042590030 worth?
The government has obligated $28,073,294 on 140D042590030. Its potential value, with all options, is $32,751,928.
Which agency awarded contract 140D042590030?
Interior Business Center (Office of Policy Management and Budget) awarded 140D042590030, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D042590030 competed?
The extent of competition for 140D042590030 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award